Log In
BCIQ
Print this Print this
 

Granexin Gel (ACT 1)

  Manage Alerts
Collapse Summary General Information
Company FirstString Research Inc.
DescriptionBioengineered peptide gel mimetic of the carboxyl-terminus of gap junction protein alpha 1, 43kDa (GJA1; X43; connexin-43)
Molecular Target Gap junction protein alpha 1, 43kDa (GJA1) (CX43) (connexin-43)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/27/2016

Undisclosed

0

0

Get a free BioCentury trial today